Still plenty of reasons for MSB to run that additional phase 3 COVID-19 ARDS trial if the NIH are paying for it ..... somewhere between 2,000 - 3,000 people are still dying each week in the USA from COVID-19 / COVID-19 ARDS
https://www.nytimes.com/
The UK still is seeing roughly the same number of people per capita dying as the USA when population / death ratios are taken into consideration
https://coronavirus.data.gov.uk/
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-392
-
- There are more pages in this discussion • 514 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |